Endosialin	0	10	B-Gene_or_gene_product
/	10	11	O
TEM	11	14	B-Gene_or_gene_product
1	15	16	I-Gene_or_gene_product
/	16	17	O
CD248	17	22	B-Gene_or_gene_product
is	23	25	O
a	26	27	O
pericyte	28	36	B-Cell
marker	37	43	O
of	44	46	O
embryonic	47	56	O
and	57	60	O
tumor	61	66	B-Pathological_formation
neovascularization	67	85	O
.	85	86	O

The	88	91	O
formation	92	101	O
of	102	104	O
functional	105	115	O
,	115	116	O
mature	117	123	O
blood	124	129	B-Multi-tissue_structure
vessels	130	137	I-Multi-tissue_structure
depends	138	145	O
on	146	148	O
the	149	152	O
interaction	153	164	O
between	165	172	O
endothelial	173	184	B-Cell
cells	185	190	I-Cell
and	191	194	O
pericytes	195	204	B-Cell
.	204	205	O

Commonality	206	217	O
exists	218	224	O
in	225	227	O
the	228	231	O
processes	232	241	O
involved	242	250	O
in	251	253	O
vasculature	254	265	B-Multi-tissue_structure
development	266	277	O
between	278	285	O
tissues	286	293	B-Tissue
whether	294	301	O
healthy	302	309	O
or	310	312	O
diseased	313	321	O
.	321	322	O

Endosialin	323	333	B-Gene_or_gene_product
/	333	334	O
TEM	334	337	B-Gene_or_gene_product
1	338	339	I-Gene_or_gene_product
is	340	342	O
a	343	344	O
cell	345	349	B-Cellular_component
membrane	350	358	I-Cellular_component
protein	359	366	O
that	367	371	O
is	372	374	O
expressed	375	384	O
in	385	387	O
blood	388	393	B-Multi-tissue_structure
vessels	394	401	I-Multi-tissue_structure
during	402	408	O
embryogenesis	409	422	O
and	423	426	O
tumorigenesis	427	440	O
but	441	444	O
not	445	448	O
in	449	451	O
normal	452	458	O
mature	459	465	B-Multi-tissue_structure
vessels	466	473	I-Multi-tissue_structure
.	473	474	O

Antibodies	475	485	O
developed	486	495	O
to	496	498	O
human	499	504	B-Organism
endosialin	505	515	B-Gene_or_gene_product
were	516	520	O
used	521	525	O
to	526	528	O
investigate	529	540	O
endosialin	541	551	B-Gene_or_gene_product
expression	552	562	O
and	563	566	O
function	567	575	O
in	576	578	O
human	579	584	B-Organism
prenatal	585	593	B-Cell
brain	594	599	I-Cell
pericytes	600	609	I-Cell
and	610	613	O
pericytes	614	623	B-Cell
residing	624	632	O
in	633	635	O
tumors	636	642	B-Pathological_formation
.	642	643	O

Anti	644	648	O
-	648	649	O
endosialin	649	659	B-Gene_or_gene_product
was	660	663	O
capable	664	671	O
of	672	674	O
preventing	675	685	O
pericyte	686	694	B-Tissue
tube	695	699	I-Tissue
formation	700	709	O
in	710	712	O
culture	713	720	O
and	721	724	O
inhibited	725	734	O
migration	735	744	O
.	744	745	O

Brain	746	751	B-Cell
pericytes	752	761	I-Cell
in	762	764	O
culture	765	772	O
had	773	776	O
higher	777	783	O
levels	784	790	O
of	791	793	O
endosialin	794	804	B-Gene_or_gene_product
/	804	805	O
TEM	805	808	B-Gene_or_gene_product
1	809	810	I-Gene_or_gene_product
than	811	815	O
TEMs	816	820	B-Gene_or_gene_product
-	820	821	I-Gene_or_gene_product
2	821	822	I-Gene_or_gene_product
,	822	823	O
-	824	825	B-Gene_or_gene_product
3	825	826	I-Gene_or_gene_product
,	826	827	O
-	828	829	B-Gene_or_gene_product
4	829	830	I-Gene_or_gene_product
,	830	831	O
-	832	833	B-Gene_or_gene_product
5	833	834	I-Gene_or_gene_product
,	834	835	O
-	836	837	B-Gene_or_gene_product
7	837	838	I-Gene_or_gene_product
,	838	839	O
and	840	843	O
-	844	845	B-Gene_or_gene_product
8	845	846	I-Gene_or_gene_product
.	846	847	O

Immunocytochemistry	848	867	O
revealed	868	876	O
that	877	881	O
endosialin	882	892	B-Gene_or_gene_product
was	893	896	O
present	897	904	O
in	905	907	O
the	908	911	O
cytoplasmic	912	923	O
body	924	928	O
and	929	932	O
in	933	935	O
the	936	939	O
elongated	940	949	O
extensions	950	960	O
essential	961	970	O
to	971	973	O
pericyte	974	982	B-Cell
function	983	991	O
.	991	992	O

Transgenic	993	1003	O
mice	1004	1008	B-Organism
engineered	1009	1019	O
to	1020	1022	O
express	1023	1030	O
human	1031	1036	B-Organism
endosialin	1037	1047	B-Gene_or_gene_product
bred	1048	1052	O
on	1053	1055	O
an	1056	1058	O
immunocompromised	1059	1076	O
background	1077	1087	O
allowed	1088	1095	O
the	1096	1099	O
growth	1100	1106	O
of	1107	1109	O
human	1110	1115	B-Organism
tumor	1116	1121	B-Tissue
xenografts	1122	1132	I-Tissue
.	1132	1133	O

In	1134	1136	O
human	1137	1142	B-Organism
colon	1143	1148	B-Pathological_formation
carcinoma	1149	1158	I-Pathological_formation
Colo205	1159	1166	I-Pathological_formation
and	1167	1170	O
HT29	1171	1175	B-Pathological_formation
xenografts	1176	1186	O
grown	1187	1192	O
in	1193	1195	O
human	1196	1201	B-Organism
endosialin	1202	1212	B-Gene_or_gene_product
-	1212	1213	O
transgenic	1213	1223	O
mice	1224	1228	B-Organism
,	1228	1229	O
endosialin	1230	1240	B-Gene_or_gene_product
expression	1241	1251	O
was	1252	1255	O
largely	1256	1263	O
confined	1264	1272	O
to	1273	1275	O
NG2	1276	1279	B-Gene_or_gene_product
-	1279	1280	O
expressing	1280	1290	O
perivascular	1291	1303	B-Cell
cells	1304	1309	I-Cell
and	1310	1313	O
not	1314	1317	O
CD31	1318	1322	B-Gene_or_gene_product
-	1322	1323	O
positive	1323	1331	O
endothelial	1332	1343	B-Cell
cells	1344	1349	I-Cell
.	1349	1350	O

Similar	1351	1358	O
methods	1359	1366	O
applied	1367	1374	O
to	1375	1377	O
human	1378	1383	B-Organism
ovarian	1384	1391	B-Pathological_formation
and	1392	1395	O
colon	1396	1401	B-Pathological_formation
tumors	1402	1408	I-Pathological_formation
confirmed	1409	1418	O
endosialin	1419	1429	B-Gene_or_gene_product
expression	1430	1440	O
by	1441	1443	O
pericytes	1444	1453	B-Cell
.	1453	1454	O

The	1455	1458	O
data	1459	1463	O
indicate	1464	1472	O
that	1473	1477	O
endosialin	1478	1488	B-Gene_or_gene_product
is	1489	1491	O
strongly	1492	1500	O
expressed	1501	1510	O
by	1511	1513	O
pericytes	1514	1523	B-Cell
during	1524	1530	O
periods	1531	1538	O
of	1539	1541	O
active	1542	1548	O
angiogenesis	1549	1561	O
during	1562	1568	O
embryonic	1569	1578	O
and	1579	1582	O
tumor	1583	1588	B-Pathological_formation
development	1589	1600	O
.	1600	1601	O

Anti	1602	1606	O
-	1606	1607	O
endosialin	1607	1617	B-Gene_or_gene_product
antibodies	1618	1628	O
may	1629	1632	O
have	1633	1637	O
value	1638	1643	O
in	1644	1646	O
identifying	1647	1658	O
vasculature	1659	1670	B-Multi-tissue_structure
in	1671	1673	O
malignant	1674	1683	B-Tissue
tissues	1684	1691	I-Tissue
.	1691	1692	O

With	1693	1697	O
the	1698	1701	O
appropriate	1702	1713	O
agent	1714	1719	O
,	1719	1720	O
targeting	1721	1730	O
endosialin	1731	1741	B-Gene_or_gene_product
may	1742	1745	O
interfere	1746	1755	O
with	1756	1760	O
blood	1761	1766	B-Multi-tissue_structure
vessel	1767	1773	I-Multi-tissue_structure
growth	1774	1780	O
during	1781	1787	O
tumor	1788	1793	B-Pathological_formation
development	1794	1805	O
.	1805	1806	O

